I. KUZU Et Al. , "Molecular Alterations Obtained by High Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targetted Therapies," Multiple miyelom AMP kongre 2021 , 2021
KUZU, I. Et Al. 2021. Molecular Alterations Obtained by High Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targetted Therapies. Multiple miyelom AMP kongre 2021 .
KUZU, I., SEVAL, G. C., YÜKSEL, S., Kaygusuz, G., DALVA, K., ÖZCAN, M., ... BEKSAÇ, M.(2021). Molecular Alterations Obtained by High Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targetted Therapies . Multiple miyelom AMP kongre 2021
KUZU, IŞINSU Et Al. "Molecular Alterations Obtained by High Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targetted Therapies," Multiple miyelom AMP kongre 2021, 2021
KUZU, IŞINSU Et Al. "Molecular Alterations Obtained by High Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targetted Therapies." Multiple miyelom AMP kongre 2021 , 2021
KUZU, I. Et Al. (2021) . "Molecular Alterations Obtained by High Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targetted Therapies." Multiple miyelom AMP kongre 2021 .
@conferencepaper{conferencepaper, author={IŞINSU KUZU Et Al. }, title={Molecular Alterations Obtained by High Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targetted Therapies}, congress name={Multiple miyelom AMP kongre 2021}, city={}, country={}, year={2021}}